Anthropic signs enterprise AI deal with Bristol Myers Squibb

Claude will be deployed across BMS to assist with drug discovery, clinical development, regulatory submissions, manufacturing operations and commercial workflows. Global biopharma company Bristol Myers Squibb (BMS) announced a strategic agreement with AI safety and research company Anthropic to deploy Claude throughout its research, manufacturing, corporate, clinical development and commercial functions. Bristol said the deployment will focus on three areas of its business: implementing Claude Code within engineering and data science teams for AI and software development, embedding agents into workflows and connecting Claude to BMS's "institutional knowledge." The company's research teams will have access to Claude to aid in…

Source: MobiHealthNews